Substituted Pyridine Sodium Channel Blockers for Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current sodium channel-blocking agents have limited efficacy and undesirable side effects for treating pain and other disorders related to sodium channel activity, necessitating the development of more effective and safer analgesics.
Innovation Solution
The use of novel substituted pyridine and pyrimidine compounds as blockers of sodium channels, represented by Formulae I-V, and their pharmaceutically acceptable salts, prodrugs, and solvates, for treating various disorders responsive to sodium channel blockade.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current sodium channel-blocking agents are used, then sodium channels are blocked, but side effects increase and efficacy is limited
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of sodium channel blockers through specific substitutions on the pyridine and pyrimidine cores. By varying substituents at different positions (R1-R6 groups) and their configurations, the invention optimizes the balance between blocking efficacy and side effect profile, achieving improved therapeutic index compared to existing agents
Solution Approach 2:
The invention employs local quality by introducing specific functional groups at particular positions on the heterocyclic ring structure. The differentiated substitution patterns (e.g., specific R groups at R1-R6 positions) create localized chemical properties that enhance selective binding to sodium channels while minimizing off-target effects, thereby improving efficacy and reducing side effects simultaneously
2Reliability
If novel substituted pyridine and pyrimidine compounds are developed, then efficacy is improved, but device complexity increases
Solution Approach 1:
The patent achieves universality by designing a core pyridine/pyrimidine structure that serves multiple therapeutic purposes. The fundamental heterocyclic scaffold with standardized substitution patterns can address various sodium channel-related disorders (pain, epilepsy, arrhythmia) while maintaining a consistent molecular framework, thus improving efficacy without proportionally increasing complexity
Data Source
AI summary
The invention relates to substituted pyridine and pyrimidine compounds of Formula (I) and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein R1, R2a, R2b, A1, A2, X, and Z are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.